All In Biotech

Drug Trial Radar · NCT04990284

eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.

A Randomized, Parallel Group, Multicentre, Multinational, Prospective, Open-label Exploratory Study to Evaluate the add-on Effect of Opicapone 50 mg or Levodopa 100 mg as First Strategy for the Treatment of Wearing-off in Patients With Parkinson's Disease.

Last checked: Nov 19, 2026Latest source record: Mar 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 106 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

106

Actual

Start

Nov 29, 2021

Primary completion

Apr 4, 2023

Study completion Apr 4, 2023

Sponsor

Lead sponsor
Bial - Portela C S.A.Industry
Sponsor type
Industry
First posted
Aug 4, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 30 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a randomized, parallel group, multicentre, multinational, prospective, open-label exploratory study in Parkinson's disease (PD) patients to evaluate the add-on efficacy of opicapone 50 mg or an extra dose of levodopa (L-DOPA) 100 mg as first strategy for the treatment of wearing-off.

Conditions

  • Parkinson Disease

Interventions

  • OpicaponeDrug

    50 mg hard capsules. Oral administration, once-daily at bedtime, at least 1 hour before or after L-DOPA/carbidopa or benserazide (L-DOPA/DDCI).

  • L-DOPA/DDCIDrug

    L-DOPA/carbidopa or benserazide (L-DOPA/DDCI), 100/25 mg, oral administration

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in Absolute OFF-time from baseline to end of studyTime frame: up to 7 weeks
  2. Proportion of patients with one hour or more reduction in Absolute OFF-time from baseline to end of study (OFF-time responders)Time frame: up to 7 weeks
  3. Change in Absolute ON-time from baseline to end of studyTime frame: up to 7 weeks
  4. Proportion of patients with one hour or more increase in Absolute ON-time from baseline to end of study (ON-time responders)Time frame: up to 7 weeks
  5. Change in Percentage OFF-time between baseline and end of studyTime frame: up to 7 weeks
  6. Change in Percentage ON-time between baseline and end of studyTime frame: up to 7 weeks

Locations

25 sites in 5 countries. Site status is shown where the registry gives one.

  • Charite Universitaetsmedizin Berlin - Campus Benjamin Franklin

    Berlin, Germany

  • Praxis Dr. med. Kirsten Hahn

    Berlin, Germany

  • Universitaetsklinikum Freiburg

    Freiburg im Breisgau, Baden-Wurttemberg, Germany

  • Parkinson-Klinik Ortenau GmbH&Co KG

    Wolfach, Baden-Wurttemberg, Germany

  • Klinik Haag i. OB

    Haag in Oberbayern, Bavaria, Germany

  • Universitaetsklinikum Wuerzburg

    Würzburg, Bavaria, Germany

  • Praxis Dr. Oehlwein

    Gera, Thuringia, Germany

  • Asklepios Fachklinikum Stadtroda

    Stadtroda, Thuringia, Germany

  • Fondazione IRCCS CA' Granda Ospedale Maggiore Policlinico

    Milan, Italy

  • Azienda Ospedaliera Universitaria- Università degli Studi della Campania "Luigi Vanvitelli"

    Naples, Italy

  • Azienda Ospedaliero Universitaria Pisana

    Pisa, Italy

  • Azienda Ospedaliera Santa Maria di Terni

    Terni, Italy

  • Hospital Beatriz Ângelo

    Loures, Lisbon District, Portugal

  • CNS-Campus Neurologico Senior

    Torres Vedras, Lisbon District, Portugal

  • Hospital Universitari Vall d'Hebron

    Barcelona, Spain

  • Hospital Ruber Internacional

    Madrid, Spain

  • Complejo Hospitalario Universitario de Orense

    Ourense, Spain

  • Hospital General Universitario de Elche

    Elche, Alicante, Spain

  • Hospital de Sant Joan Despi Moises Broggi

    Sant Joan Despí, Barcelona, Spain

  • Complejo Hospitalario Universitario A Coruña

    A Coruña, La Coruña, Spain

  • Hospital Universitario Puerta de Hierro Majadahonda

    Majadahonda, Madrid, Spain

  • Royal Devon and Exeter Hospital (Wonford)

    Exeter, Devon, United Kingdom

  • University Hospitals Plymouth

    Plymouth, Devon, United Kingdom

  • King's College Hospital

    London, Greater London, United Kingdom

  • Newcastle University- Clinical Ageing Research Unit

    Newcastle upon Tyne, Tyne & Wear, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.